Nuo Therapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Nuo Therapeutics, Inc. reported Earnings Per Share Diluted of $0.03 (loss) per share for the year ending 2021.

  • Nuo Therapeutics, Inc. showed a decrease of -111.1% in Earnings Per Share Diluted from 2020 to 2021.
  • This data is from Nuo Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2022.
  • XBRL data for this metric is available from 2017 to 2021 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2017 to 2021), Nuo Therapeutics, Inc.'s Earnings Per Share Diluted has grown by 97.1%.
  • Historical annual values: Fiscal year 2021: $0.03 (loss) per share | Fiscal year 2020: $0.27 per share | Fiscal year 2019: $0.05 (loss) per share | Fiscal year 2018: $0.07 (loss) per share | Fiscal year 2017: $1.02 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: